ArticleEndocrinology, diabetes & metabolism2026
Interaction and Joint Effects of Inflammation and Triglyceride-Glucose (TyG) Index on Hyperuricemia Risk and the Mediating Role of TyG: A Cross-Sectional Study.
Article in Endocrinology, diabetes & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Obesity as the Upstream Driver of Inflammation and Insulin Resistance in Hyperuricaemia.Endocrinology, diabetes & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe chronic inflammation and insulin resistance (IR) are implicated in hyperuricemia (HUA) pathogenesis, while their interplay remains inadequately characterised. This study aimed to investigate their independent, interactive, and combined effects on HUA risk and serum uric acid (UA) levels, and to quantify the mediating effect of IR in the Southern Chinese population.
methodsA cross-sectional study was conducted among 5307 Chinese adults. The triglyceride-glucose (TyG) index served as an alternative marker for IR, and a modified inflammation (mINFLA) score, comprising white blood cell (WBC) count, platelet (PLT) count, and the neutrophil-to-lymphocyte ratio (NLR), was used to assess systemic low-grade inflammation. The multivariable logistic and linear regression models were employed to explore the associations of the TyG index and mINFLA score with HUA risk and UA levels, and the interaction effects and mediating role of the TyG index were further assessed. Subgroup analyses were stratified by age, sex, and disease status.
resultsAmong 5307 Chinese adults, a higher TyG index and a higher mINFLA score were significantly associated with an increased HUA risk and elevated UA levels, demonstrating significant dose-response relationships (p for trend < 0.001). A significant interaction was observed between the TyG index and mINFLA score in relation to HUA risk and UA levels. Participants exhibiting both high TyG index and mINFLA score had the highest HUA risk and UA levels. Notably, mediation analysis revealed that the TyG index significantly explained 15.4% of the association between the mINFLA score and HUA risk, and 14.5% of the association with UA levels.
conclusionChronic inflammation is an independent risk factor for hyperuricemia, with insulin resistance serving as a key mediating factor. Furthermore, these two factors exhibit a significant joint effect on hyperuricemia risk. These findings underscore the importance of simultaneously considering both insulin resistance and chronic inflammation in hyperuricemia prevention and management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.